Sinovac Biotech
| Company type | Public | ||||||
|---|---|---|---|---|---|---|---|
| Nasdaq: SVA | |||||||
| Founded | 1999 | ||||||
| Founder | Yin Weidong | ||||||
| Headquarters | 39 Shang Di West Road, Haidian District, , China | ||||||
Number of employees | 4,281 (as of 2022) | ||||||
| Chinese name | |||||||
| Simplified Chinese | 科兴控股生物技术有限公司 | ||||||
| Traditional Chinese | 科興控股生物技術有限公司 | ||||||
| Literal meaning | Kexing Holdings Biotechnology Co., Ltd. | ||||||
| |||||||
| Website | www | ||||||
Sinovac Biotech Ltd. (Chinese: 科兴控股生物技术有限公司) is a Chinese biopharmaceutical company based in Haidian District, Beijing that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company was listed on the Nasdaq but the exchange halted Sinovac's trading in February 2019 due to a proxy fight. The company has faced bribery probes in China.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.